Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT
Purpose
The purpose of this paper was to determine the validity of using a single tissue microarray core (TMA) for immunohistochemical analysis of the following breast cancer markers, estrogen receptor (ER), progesterone receptor (PR), p27, the estrogen receptor co-regulator amplified in breast cancer 1 (AIB1), B-cell lymphoma 2 (Bcl-2), pS2, cyclooxygenase 2 (COX-2), human epidermal growth factor receptor 2 (HER-2), insulin-like growth factor 1 receptor (IGF-1R).
Conclusion
The authors conclude that the significant association that was observed for breast cancer relevant markers between 2.0 mm TMA cores and corresponding whole tissue sections validate the sole use of TMA cores for immunohistochemistry. However, it is worthy to note that while the degree of concordance was high for positive/negative case status (86-100%), Allred scores (a scoring method that evaluates the extent and intensity of immunostaining) were more variable as identical results were observed in only 64% of TMA and whole section cohorts. Significant discrepancies in Allred scores for p27, Bcl-2, and pS2 were also observed among TMA cores and whole sections.
Studies (1)
Purpose
This study sought to determine whether immunohistochemical staining of nuclear (ER, PR, p27, AIB1), cytoplasmic (COX-2, pS2, Bcl-2), and membrane (HER-2, EGFR, IGF-IR) markers of breast cancer in a single 2.0 mm TMA core are representative of staining observed in a corresponding whole tissue section. A total of 55 tumors were evaluated, staining was analyzed by the Allred scoring method, and concordance was determined by the kappa score.
Summary of Findings
Allred scores for all 8 markers were identical in 64% of tumors when a 2.0 mm TMA core and a whole tissue section were compared, while identical scores for a specific marker ranged between 44% (p27) and 93% (HER-2). EGFR, HER-2, and IGF-IR scores displayed the highest degree of concordance between case-matched TMA cores and whole sections, as identical Allred scores were observed in 100%, 93%, and 69% of tumors, respectively. Importantly, 100% tumors were EGFR negative. The magnitude of difference in Allred scores between TMA cores and whole sections was marker-specific, with the largest degree of variability observed for p27, Bcl-2, and PR immunostaining. A Wilcoxon's signed rank sum test identified significant discrepancies among scores obtained from TMA and whole sections for p27, Bcl-2, and pS2, which displayed higher scores in whole sections. Kappa scores were as follows: HER-2, k=0.88; Bcl-2, k=0.58; IGF-IR, k=0.49; ER, k=0.49; PR, k=0.48; AIB1, k=0.46; COX-2, k=0.43; pS2, k=0.43. When positive versus negative case status was examined among TMA and whole tissue sections for each marker, concordance exceeded 90% for six markers, with a concordance of 86% and 87% observed for pS2 and p27, respectively.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryProteinTissue microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Type of slide Tissue microarrayWhole tissue sectionImmunohistochemistry Specific Targeted peptide/protein AIB1COX-2ERHER-2IGF-IRPRp27pS2